Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-12-009965
Filing Date
2012-06-11
Accepted
2012-06-11 17:21:21
Documents
2
Period of Report
2012-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2240
2 TILLY POA tilly_061112poa.txt EX-24.TXT 3964
  Complete submission text file 0001179110-12-009965.txt   7562
Mailing Address 800 BOYLSTON STREET, SUITE 1555 BOSTON MA 02199
Business Address 800 BOYLSTON STREET, SUITE 1555 BOSTON MA 02199 617-351-2590
OvaScience, Inc. (Issuer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O OVASCIENCE, INC. 41 LINSKEY WAY, LEVEL B CAMBRIDGE MA 02142
Business Address
Tilly Jonathan L (Reporting) CIK: 0001551698 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54647 | Film No.: 12901322